KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation ExpenseEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Medpace Holdings (MEDP) Depreciation Expense (2016 - 2026)

Medpace Holdings filings provide 12 years of Depreciation Expense readings, the most recent being $6.8 million for Q1 2026.

  • On a quarterly basis, Depreciation Expense rose 0.85% to $6.8 million in Q1 2026 year-over-year; TTM through Mar 2026 was $27.3 million, a 2.17% decrease, with the full-year FY2025 number at $27.2 million, down 2.16% from a year prior.
  • Depreciation Expense hit $6.8 million in Q1 2026 for Medpace Holdings, down from $6.9 million in the prior quarter.
  • In the past five years, Depreciation Expense ranged from a high of $7.2 million in Q3 2024 to a low of $4.3 million in Q1 2022.
  • Median Depreciation Expense over the past 5 years was $6.6 million (2024), compared with a mean of $6.2 million.
  • Biggest five-year swings in Depreciation Expense: grew 27.83% in 2023 and later fell 4.82% in 2025.
  • Medpace Holdings' Depreciation Expense stood at $5.1 million in 2022, then grew by 26.89% to $6.4 million in 2023, then rose by 11.13% to $7.1 million in 2024, then decreased by 3.1% to $6.9 million in 2025, then decreased by 2.39% to $6.8 million in 2026.
  • The last three reported values for Depreciation Expense were $6.8 million (Q1 2026), $6.9 million (Q4 2025), and $6.8 million (Q3 2025) per Business Quant data.